| Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study S Blach, S Zeuzem, M Manns, I Altraif, AS Duberg, DH Muljono, I Waked, ... The lancet Gastroenterology & hepatology 2 (3), 161-176, 2017 | 2075 | 2017 |
| Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis B CL Lai, D Shouval, AS Lok, TT Chang, H Cheinquer, Z Goodman, ... New England Journal of Medicine 354 (10), 1011-1020, 2006 | 1681 | 2006 |
| The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm H Razavi, I Waked, C Sarrazin, RP Myers, R Idilman, F Calinas, W Vogel, ... Journal of viral hepatitis 21, 34-59, 2014 | 558 | 2014 |
| Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission GS Cooke, I Andrieux-Meyer, TL Applegate, R Atun, JR Burry, ... The lancet Gastroenterology & hepatology 4 (2), 135-184, 2019 | 502* | 2019 |
| Historical epidemiology of hepatitis C virus (HCV) in selected countries P Bruggmann, T Berg, ALH Øvrehus, C Moreno, CE Brandão Mello, ... Journal of viral hepatitis 21, 5-33, 2014 | 411 | 2014 |
| Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study S Blach, NA Terrault, F Tacke, I Gamkrelidze, A Craxi, J Tanaka, I Waked, ... The Lancet Gastroenterology & Hepatology 7 (5), 396-415, 2022 | 303 | 2022 |
| Strategies to manage hepatitis C virus (HCV) disease burden H Wedemeyer, AS Duberg, M Buti, WM Rosenberg, S Frankova, G Esmat, ... Journal of viral hepatitis 21, 60-89, 2014 | 272 | 2014 |
| Efficacy and safety of entecavir versus adefovir in chronic hepatitis B patients with hepatic decompensation: a randomized, open‐label study YF Liaw, M Raptopoulou‐Gigi, H Cheinquer, SK Sarin, T Tanwandee, ... Hepatology 54 (1), 91-100, 2011 | 269 | 2011 |
| Peginterferon alfa-2a (40 kD)(PEGASYS) in combination with ribavirin (RBV): efficacy and safety results from a phase III, randomized, double-blind, multicentre study examining … SJ Hadziyannis, H Cheinquer, T Morgan, M Diago, DM Jensen, H Sette, ... Elsevier Science Bv, 2002 | 222 | 2002 |
| Viral pathogenesis of hepatocellular carcinoma in the United States TJ Liang, LJ Jeffers, KR Reddy, M De Medina, IT Parker, H Cheinquer, ... Hepatology 18 (6), 1326-1333, 1993 | 180 | 1993 |
| Fulminant or subfulminant non-A, non-B viral hepatitis: the role of hepatitis C and E viruses TJ Liang, L Jeffers, RK Reddy, MO Silva, H Cheinquer, A Findor, ... Gastroenterology 104 (2), 556-562, 1993 | 180 | 1993 |
| Relapse of hepatitis B in HBeAg-negative chronic hepatitis B patients who discontinued successful entecavir treatment: the case for continuous antiviral therapy D Shouval, CL Lai, TT Chang, H Cheinquer, P Martin, G Carosi, S Han, ... Journal of hepatology 50 (2), 289-295, 2009 | 142 | 2009 |
| High sustained virologic response rates in rapid virologic response patients in the large real‐world PROPHESYS cohort confirm results from randomized clinical trials P Marcellin, H Cheinquer, M Curescu, GM Dusheiko, P Ferenci, A Horban, ... Hepatology 56 (6), 2039-2050, 2012 | 123 | 2012 |
| Disease burden of chronic hepatitis C in Brazil PRA Ferreira, CE Brandão-Mello, C Estes, FL Gonçales, HSM Coelho, ... Brazilian Journal of Infectious Diseases 19 (4), 363-368, 2015 | 100 | 2015 |
| Outcomes of long-term treatment of chronic HBV infection with entecavir or other agents from a randomized trial in 24 countries JL Hou, W Zhao, C Lee, HW Hann, CY Peng, T Tanwandee, V Morozov, ... Clinical Gastroenterology and Hepatology 18 (2), 457-467. e21, 2020 | 94 | 2020 |
| Treatment with direct‐acting antivirals for HCV decreases but does not eliminate the risk of hepatocellular carcinoma F Piñero, M Mendizabal, E Ridruejo, F Herz Wolff, B Ameigeiras, ... Liver International 39 (6), 1033-1043, 2019 | 77 | 2019 |
| Cost-effectiveness of combination peginterferon α-2a and ribavirin compared with interferon α-2b and ribavirin in patients with chronic hepatitis C SD Sullivan, DM Jensen, DE Bernstein, TI Hassanein, GR Foster, SS Lee, ... Official journal of the American College of Gastroenterology| ACG 99 (8 …, 2004 | 71 | 2004 |
| Hepatitis C virus genotypes in Southern Brazil LP Krug, VR Lunge, N Ikuta, ASK Fonseca, H Cheinquer, LS Ozaki, ... Brazilian journal of medical and biological research= Revista brasileira de …, 1996 | 69 | 1996 |
| Disease progression in patients with hepatitis C virus infection treated with direct-acting antiviral agents M Mendizabal, F Piñero, E Ridruejo, FH Wolff, M Anders, V Reggiardo, ... Clinical Gastroenterology and Hepatology 18 (11), 2554-2563. e3, 2020 | 61 | 2020 |
| Entecavir demonstrates superior histologic and virologic efficacy over lamivudine in nucleoside-naïve HBeAg (-) chronic hepatitis B: results of phase III trial ETV-027. D Shouval, CL Lai, H Cheinquer, A Lok, D DeHertogh, R Wilber, A Cross, ... Hepatology 40 (4), 728A-728A, 2004 | 58 | 2004 |
